Table 1.
Antagonist | Nicardipine | ω-conotoxin GVIA | ω-Agatoxin TK | SNX-482 | TTA-P2 |
---|---|---|---|---|---|
Concentration | 20 µM | 1 µM | 1 µM | 1 µM | 1 µM |
Ca2+ channel antagonist | CaV1 | CaV2.2 | CaV2.1 | CaV2.3 | CaV3 |
% of current blocked (mean ± S.E.M) | 38 ± 1.1 | 23.4 ± 0.7 | 11.1 ± 1.4 | 20 ± 2 | 7.4 ± 2.3 |
n | 12 | 14 | 14 | 6 | 13 |
p | 0.0001 | 0.0001 | 0.0033 | 0.0009 | 0.0202 |
The first row (not counting the title) indicates the Ca2+ channel antagonist used. The second row contains saturating concentrations used. Third row stands for the specific Ca2+ channel class that was blocked. The fourth row displays the mean ± SEM of Ca2+ current blocked in percentage by each antagonist. Antagonists were tested alone or in sequence in different orders. Percentages were obtained from a system of linear equations that used data from all experiments (see Materials and methods). The fifth row shows samples size: the number of neurons tested with each antagonist. The sixth row indicates statistical significance or P-value of percentage blockade by each antagonist as compared to whole-cell current average before adding any antagonist (Kruskal–Wallis ANOVA with post hoc Dunn’s test of each paired comparison against the control: whole-cell Ca2+ current)